发明名称 RNA isolation from soluble urine fractions
摘要 The invention provides methods for isolating RNA from the soluble fraction of urine. The methods can be used for detecting the presence or absence of an RNA, or quantifying the amount of an RNA. The methods are useful for diagnosing an individual suspected of having a disease by detecting the level of RNA associated with the disease in the soluble fraction of urine. The methods are also useful for prognosing an individual diagnosed with a disease by detecting the level of RNA associated with the disease in the soluble fraction of urine.
申请公布号 US9315802(B2) 申请公布日期 2016.04.19
申请号 US201012973747 申请日期 2010.12.20
申请人 QUEST DIAGNOSTICS INVESTMENTS INCORPORATED 发明人 Sanders Heather;Li Hai-Rong
分类号 C12Q1/68;C12N15/10 主分类号 C12Q1/68
代理机构 Foley & Lardner LLP 代理人 Foley & Lardner LLP
主权项 1. A method for processing urine for detection of RNA expression associated with a benign prostate hyperplasia, comprising: a) separating urine sediment from the soluble urine fraction of a urine sample obtained from an individual suspected of having cancer, wherein RNA associated with the benign prostate hyperplasia is present in the soluble urine fraction; and b) concentrating the soluble urine fraction by ultrafiltration to produce a soluble urine concentrate, wherein the volume of the soluble urine concentrate is reduced at least 50% from the original urine volume, wherein the benign prostate hyperplasia-associated RNA is selected from the group consisting of HSPD1, IMPDH2, PDLIM5, and UAP1.
地址 Wilmington DE US